Considering Changes in the Recommended Human Chorionic Gonadotropin Monitoring After Molar Evacuation
Neil S Horowitz1, Ross S Berkowitz, Kevin M Elias
1From the New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts;
Obstetrics and Gynecology
|December 7, 2019
Abstract
No abstract available in PubMed .


